Rezolute (RZLT) Retained Earnings (2011 - 2026)
Rezolute (RZLT) posted Retained Earnings of -$461.0 million for Q1 2026, down 980846.81% sequentially from $47000.0 in Q4 2025, and down 21.47% YoY from -$587.0 million in Q1 2025.
Analysis
Rezolute (RZLT) Retained Earnings (2011 - 2026) Analysis & Trends
Rezolute has reported Retained Earnings for 16 years, with the latest figure at -$461.0 million in Q1 2026.
- Quarterly Retained Earnings fell 21.47% year-over-year to -$461.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$461.0 million (down 21.47% YoY) and the FY2025 annual result came in at $565.9 million, up 716432.91% from the prior year.
- Retained Earnings retreated to -$461.0 million in Q1 2026 per RZLT's latest filing, from $47000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $569.0 million in Q3 2025 and troughed at -$461.0 million in Q1 2026.
- A 5-year average of -$40.5 million and a median of -$219.0 million in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 716432.91% in 2025, down 200.56% in 2025.
- Over 5 years, Retained Earnings stood at -$232.6 million in 2022, then fell by 24.43% to -$289.4 million in 2023, then retreated by 24.6% to -$360.6 million in 2024, then surged by 100.01% to $47000.0 in 2025, then tumbled by 980846.81% to -$461.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$461.0 million, $47000.0, and $569.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 577.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 577.80 Mn |
| Dec 31, 2025 | 572.64 Mn |
| Sep 30, 2025 | 569.03 Mn |
| Jun 30, 2025 | 565.90 Mn |
| Mar 31, 2025 | 461.93 Mn |
| Dec 31, 2024 | 460.02 Mn |
| Sep 30, 2024 | 457.92 Mn |
| Jun 30, 2024 | 450.47 Mn |
| Mar 31, 2024 | 377.37 Mn |
| Dec 31, 2023 | 381.15 Mn |
| Sep 30, 2023 | 379.32 Mn |
| Jun 30, 2023 | 377.47 Mn |
| Mar 31, 2023 | 375.67 Mn |
| Dec 31, 2022 | 373.81 Mn |
| Sep 30, 2022 | 372.08 Mn |
| Jun 30, 2022 | 358.64 Mn |
| Mar 31, 2022 | 251.67 Mn |
| Dec 31, 2021 | 250.82 Mn |
| Sep 30, 2021 | 197.52 Mn |
| Jun 30, 2021 | 194.23 Mn |